David M Parham Selected Research

David M Parham Research Topics

Disease

20	Neoplasms (Cancer) 04/2024 - 03/2002
13	Rhabdomyosarcoma 01/2019 - 05/2006
7	Sarcoma (Soft Tissue Sarcoma) 04/2024 - 04/2011
6	Embryonal Rhabdomyosarcoma 09/2017 - 04/2005
3	Alveolar Rhabdomyosarcoma 10/2010 - 04/2005
2	Residual Neoplasm 04/2024 - 01/2017
2	Disease Progression 01/2019 - 10/2010
1	Rupture 04/2024
1	Margins of Excision 04/2024
1	Neoplasm Metastasis (Metastasis) 01/2023
1	Anaplasia 01/2021
1	Wounds and Injuries (Trauma) 01/2020
1	Dermatofibrosarcoma 01/2020
1	Osteosarcoma (Osteogenic Sarcoma) 01/2018
1	Infertility (Sterility) 09/2017
1	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2017
1	Hamartoma 01/2017
1	Breast Neoplasms (Breast Cancer) 01/2017
1	Hepatocellular Carcinoma (Hepatoma) 12/2015
1	Hepatoblastoma 12/2015
1	Granuloma 12/2014
1	Entropion 12/2014
1	Foreign Bodies (Foreign Body) 12/2014
1	Dermatomyositis (Dermatopolymyositis) 03/2013
1	Hyperplasia 09/2012
1	Lung Diseases (Lung Disease) 09/2012
1	Emphysema 09/2012
1	Arteriosclerosis 09/2012
1	Schimke immunoosseous dysplasia 09/2012
1	Aicardi Syndrome 01/2011
1	Lymphedema (Milroy Disease) 01/2011
1	Hemangioma (Angioma) 01/2011
1	Melanotic Neuroectodermal Tumor 03/2007
1	Neuroepithelial Neoplasms (Gliomatosis Cerebri) 02/2007
1	Wilms Tumor (Wilm's Tumor) 02/2007
1	Necrosis 08/2006
1	Fat Embolism 05/2006
1	Scoliosis 05/2006
1	Carcinogenesis 03/2003

Drug/Important Bio-Agent (IBA)

7	Vincristine (Oncovin)FDA LinkGeneric 01/2018 - 11/2009
6	MyogeninIBA 03/2021 - 11/2004
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2018 - 11/2009
5	Dactinomycin (Actinomycin)FDA LinkGeneric 01/2018 - 11/2009
3	DNA (Deoxyribonucleic Acid)IBA 11/2018 - 03/2003
3	Irinotecan (Camptosar)FDA LinkGeneric 01/2018 - 10/2010
2	DesminIBA 03/2021 - 11/2004
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 05/2014
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 12/2015
2	ChromatinIBA 09/2012 - 10/2010
2	ParaffinIBA 06/2006 - 05/2006
1	Histones (Histone)IBA 04/2024
1	Lysine (L-Lysine)FDA Link 04/2024
1	Indicators and Reagents (Reagents)IBA 01/2021
1	cixutumumabIBA 01/2019
1	Temozolomide (Temodar)FDA LinkGeneric 01/2019
1	epacadostatIBA 01/2018
1	human ERBB2 proteinIBA 01/2017
1	Trastuzumab (Herceptin)FDA Link 01/2017
1	Monoclonal AntibodiesIBA 01/2017
1	Etoposide (VP 16)FDA LinkGeneric 01/2016
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2016
1	Ifosfamide FDA LinkGeneric 01/2016
1	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 12/2015
1	GlypicansIBA 12/2015
1	delta proteinIBA 12/2015
1	Claudin-1IBA 12/2015
1	CateninsIBA 12/2015
1	Polyglycolic Acid (Polyglycolide)IBA 12/2014
1	ElementsIBA 12/2014
1	Contrast MediaIBA 12/2014
1	ElastinIBA 09/2012
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 10/2010
1	Topotecan (Hycamtin)FDA LinkGeneric 11/2009
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 02/2007
1	Coloring Agents (Dyes)IBA 02/2007
1	Formaldehyde (Formol)FDA Link 05/2006
1	EnzymesIBA 04/2005
1	Culture MediaIBA 03/2004
1	Satellite DNA (Satellite DNAs)IBA 03/2003
1	HeterochromatinIBA 03/2003

Therapy/Procedure

10	Therapeutics 01/2020 - 03/2002
8	Radiotherapy 04/2024 - 10/2010
8	Drug Therapy (Chemotherapy) 04/2024 - 03/2002
3	Neoadjuvant Therapy 04/2024 - 01/2017
1	Chemoradiotherapy 01/2020
1	Surgical Amputation (Amputations) 01/2017
1	Sutures (Suture) 12/2014
1	Immunomodulation 03/2013
1	Liver Transplantation 06/2007
1	Spinal Fusion (Spondylosyndesis) 05/2006